Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

MorphoSys confirms 2015 guidance

Country: Germany

MorphoSys AG has confirmed its financial guidance for 2015 with expectations of revenue of between €101 and €106 million, and earnings before interest and tax of €9 to €16 million. This follows an eventful period during which it saw a multi-year partnership with Celgene Corp end. 

Read more

Malaria vaccine passes first regulatory hurdle

Country: United Kingdom

 A new vaccine designed to protect young children in sub-Saharan Africa from infection from thePlasmodium falciparum parasite has been given a positive opinion by the European Medicines Agency even as its effectiveness was described as modest.

Read more

Oxford Nanopore raises ÂŁ70 million in equity

Country: United Kingdom

Read more

Roche confirms 2015 sales outlook

Country: Switzerland

Read more

Shire takes second quarter hit

Country: Ireland

Read more

Novartis results boosted by Sandoz division

Country: Switzerland

Read more

New structure for Sanofi

Country: France

Read more

Immunocore raises $320 million in private financing

Country: United Kingdom

Read more

US biomedical bill passes House

Country: United States

Read more

EMA starts safety review of HPV vaccines

Country: United Kingdom

Read more

ReNeuron outlines three-year strategy

Country: United Kingdom

Read more

Autifony obtains more Series A money

Country: United Kingdom

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

The sky is the limit as Celgene invests in Juno

subscribers only

Highlights of the June 2015 MedNous issue

The June 2015 MedNous features:

Latest Mednous cover
  • Financial Strategy
    Identifying promising assets early
    Interview with Novo Seeds
  • Business Strategy
    Virtual drug development at Verona Pharma
  • Commentary
    Tackling paediatric cancer
    By Jérôme Van Biervliet
  • Commentary
    Patent filings for antibiotics lag
    by Jennifer Bailey
  • Commentary
    Achieving safe and timely access to new medicines
    By Johan Strômquist

The latest MedNous journal. Subscribe to download.